178 related articles for article (PubMed ID: 25672586)
1. Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung Cancer.
Lee YG; Lee E; Kim I; Lee KW; Kim TM; Lee SH; Kim DW; Heo DS
Cancer Res Treat; 2015 Oct; 47(4):670-5. PubMed ID: 25672586
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy.
Zareba P; Patterson L; Pandya R; Margel D; Hotte SJ; Mukherjee SD; Elavathil L; Daya D; Shayegan B; Pinthus JH
Urol Oncol; 2014 Oct; 32(7):975-80. PubMed ID: 25027682
[TBL] [Abstract][Full Text] [Related]
3. High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.
Moore RA; Adel N; Riedel E; Bhutani M; Feldman DR; Tabbara NE; Soff G; Parameswaran R; Hassoun H
J Clin Oncol; 2011 Sep; 29(25):3466-73. PubMed ID: 21810688
[TBL] [Abstract][Full Text] [Related]
4. Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
Kim ES; Baran AM; Mondo EL; Rodgers TD; Nielsen GC; Dougherty DW; Pandya KJ; Rich DQ; van Wijngaarden E
PLoS One; 2017; 12(12):e0189410. PubMed ID: 29228042
[TBL] [Abstract][Full Text] [Related]
5. Retrospective evaluation of thromboembolic events in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
Mellema WW; van der Hoek D; Postmus PE; Smit EF
Lung Cancer; 2014 Oct; 86(1):73-7. PubMed ID: 25129368
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer.
Miyoshi T; Misumi N; Hiraike M; Mihara Y; Nishino T; Tsuruta M; Kawamata Y; Hiraki Y; Kozono A; Ichiki M
Biol Pharm Bull; 2016; 39(12):2009-2014. PubMed ID: 27904042
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.
Zahir MN; Shaikh Q; Shabbir-Moosajee M; Jabbar AA
BMC Cancer; 2017 Jan; 17(1):57. PubMed ID: 28093087
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
[TBL] [Abstract][Full Text] [Related]
9. The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area.
Piketty AC; Fléchon A; Laplanche A; Nouyrigat E; Droz JP; Théodore C; Fizazi K
Br J Cancer; 2005 Oct; 93(8):909-14. PubMed ID: 16205699
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin, Etoposide, and Bevacizumab Regimen Followed by Oral Etoposide and Bevacizumab Maintenance Treatment in Patients With Extensive-Stage Small Cell Lung Cancer: A Single-Institution Experience.
Petrioli R; Roviello G; Laera L; Luzzi L; Paladini P; Ghiribelli C; Voltolini L; Martellucci I; Bianco V; Francini E
Clin Lung Cancer; 2015 Nov; 16(6):e229-34. PubMed ID: 26072097
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
[TBL] [Abstract][Full Text] [Related]
12. Analysis of thromboembolic events in patients with non-small cell lung cancer who received adjuvant chemotherapy: single-center real-world data.
Kim TH; Choi YW; Lee HW; Kang SY; Son H; Choi JH; Ahn MS; Sheen SS
Sci Rep; 2022 May; 12(1):7646. PubMed ID: 35538092
[TBL] [Abstract][Full Text] [Related]
13. Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours.
Gizzi M; Oberic L; Massard C; Poterie A; Le Teuff G; Loriot Y; Albiges L; Baciarello G; Michels J; Bossi A; Blanchard P; Escudier B; Fizazi K
Eur J Cancer; 2016 Dec; 69():151-157. PubMed ID: 27821318
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Platinum-Sensitive Small-Cell Lung Cancer Patients Treated With Platinum/Etoposide Rechallenge: A Multi-Institutional Retrospective Analysis.
Genestreti G; Tiseo M; Kenmotsu H; Kazushige W; Di Battista M; Cavallo G; Carloni F; Bongiovanni A; Burgio MA; Casanova C; Metro G; Scarpi E; Korkmaz T; Selcuk S; Roopa K; Califano R
Clin Lung Cancer; 2015 Nov; 16(6):e223-8. PubMed ID: 25983005
[TBL] [Abstract][Full Text] [Related]
15. [The occurrence of anemia in small cell lung cancer patients during first-line chemotherapy].
Swiatoniowski G; Bruzewicz S; Bronowicz Z; Kłaniewski T
Pol Merkur Lekarski; 2009 Feb; 26(152):98-100. PubMed ID: 19388511
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
[TBL] [Abstract][Full Text] [Related]
17. Predictors of thrombosis in testicular cancer during platinum-based chemotherapy.
Paffenholz P; Grein K; Heidegger I; Nestler T; Grabbert M; Salem J; Hellmich M; Pfister D; Heidenreich A
World J Urol; 2019 Sep; 37(9):1907-1916. PubMed ID: 30547197
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolic events in patients with lung cancer treated with cisplatin-based versus carboplatin/nedaplatin-based chemotherapy.
Mitani A; Jo T; Yasunaga H; Sakamoto Y; Hasegawa W; Urushiyama H; Yamauchi Y; Matsui H; Fushimi K; Nagase T
Anticancer Drugs; 2018 Jul; 29(6):560-564. PubMed ID: 29570101
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.
Teman NR; Silski L; Zhao L; Kober M; Urba SC; Orringer MB; Chang AC; Lin J; Reddy RM
Ann Thorac Surg; 2012 Oct; 94(4):1118-24; discussion 1124-5. PubMed ID: 22858275
[TBL] [Abstract][Full Text] [Related]
20. Significance of thromboembolic phenomena occurring before and during chemoradiotherapy for localized carcinoma of the esophagus and gastroesophageal junction.
Tetzlaff ED; Correa AM; Komaki R; Swisher SG; Maru D; Ross WA; Ajani JA
Dis Esophagus; 2008; 21(7):575-81. PubMed ID: 18459989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
